SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17072984
Source:
http://linkedlifedata.com/resource/pubmed/id/17072984
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008838
,
umls-concept:C0123931
,
umls-concept:C0278498
,
umls-concept:C0282460
,
umls-concept:C0574032
pubmed:issue
40
pubmed:dateCreated
2006-10-30
pubmed:abstractText
To test protracted irinotecan infusion plus a low-dose cisplatin in this Phase II trial to decrease its toxicity.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100883448
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1007-9327
pubmed:author
pubmed-author:FujitaniKazumasaK
,
pubmed-author:FurukawaHiroshiH
,
pubmed-author:IkedaMasatakaM
,
pubmed-author:ImamotoHaruhikoH
,
pubmed-author:ImamuraHiroshiH
,
pubmed-author:KatoMichioM
,
pubmed-author:KobayashiKenjiK
,
pubmed-author:NaraharaHiroyukiH
,
pubmed-author:TakabayashiArimichiA
,
pubmed-author:TsujinakaToshimasaT
,
pubmed-author:TsukumaHideakiH
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6522-6
pubmed:meshHeading
pubmed-meshheading:17072984-Adult
,
pubmed-meshheading:17072984-Aged
,
pubmed-meshheading:17072984-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:17072984-Camptothecin
,
pubmed-meshheading:17072984-Cisplatin
,
pubmed-meshheading:17072984-Dose-Response Relationship, Drug
,
pubmed-meshheading:17072984-Drug Therapy, Combination
,
pubmed-meshheading:17072984-Female
,
pubmed-meshheading:17072984-Humans
,
pubmed-meshheading:17072984-Infusions, Intravenous
,
pubmed-meshheading:17072984-Male
,
pubmed-meshheading:17072984-Middle Aged
,
pubmed-meshheading:17072984-Neoplasm Metastasis
,
pubmed-meshheading:17072984-Stomach Neoplasms
,
pubmed-meshheading:17072984-Survival Rate
,
pubmed-meshheading:17072984-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Phase II study of protracted irinotecan infusion and a low-dose cisplatin for metastatic gastric cancer.
pubmed:affiliation
Department of Surgery, Sakai Municipal Hospital, 1-1-1, Minamiyasui-cho, Sakai, Osaka 590-0064, Japan. imamura-h@city.sakai.osaka.jp
pubmed:publicationType
Journal Article
,
Clinical Trial, Phase II